Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM) (PROMCerclage)

This study is currently recruiting participants.
Verified January 2013 by Obstetrix Medical Group
Sponsor:
Information provided by (Responsible Party):
Obstetrix Medical Group
ClinicalTrials.gov Identifier:
NCT00201656
First received: September 13, 2005
Last updated: January 2, 2013
Last verified: January 2013
  Purpose

The purpose of this study is to determine whether retention of cervical cerclage after PPROM improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.


Condition Intervention Phase
Fetal Membranes, Premature Rupture
Procedure: Retention of Cerclage
Procedure: Removal of Cerclage
Procedure: Removal vs. Retention of Cervical Cerclage
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial

Resource links provided by NLM:


Further study details as provided by Obstetrix Medical Group:

Primary Outcome Measures:
  • Chorioamnionitis as defined by temperature > 38 plus fetal tachycardia or uterine tenderness [ Time Frame: conception to birth ] [ Designated as safety issue: Yes ]
  • Composite neonatal outcome - any one of the following (for twins, either infant): Fetal or neonatal death [ Time Frame: Birth to 28days of life ] [ Designated as safety issue: Yes ]
  • Respiratory distress syndrome [ Time Frame: birth to 28days of life ] [ Designated as safety issue: Yes ]
  • Documented sepsis within 72 hours of delivery [ Time Frame: birth to 72 hours after delivery ] [ Designated as safety issue: Yes ]
  • Grade 3 or 4 intraventricular hemorrhage [ Time Frame: birth to 28days of life ] [ Designated as safety issue: Yes ]
  • Stage 2 or 3 necrotizing enterocolitis [ Time Frame: birth to 28days of life ] [ Designated as safety issue: Yes ]
  • Neonatal intensive care unit (NICU) stay [ Time Frame: birth to 28days of life ] [ Designated as safety issue: Yes ]
  • Birth weight [ Time Frame: at birth ] [ Designated as safety issue: Yes ]
  • Estimated gestational age (EGA) at delivery [ Time Frame: at delivery ] [ Designated as safety issue: Yes ]
  • Postpartum endometritis [ Time Frame: birth to 28days of life ] [ Designated as safety issue: Yes ]
  • Maternal sepsis [ Time Frame: birth to 28days following delivery ] [ Designated as safety issue: Yes ]
  • Latency [ Time Frame: labor to delivery ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 142
Study Start Date: November 2004
Estimated Study Completion Date: November 2014
Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1 Retention of Cerclage
Group one = Subject whose Cerclage is retained after randomization.
Procedure: Retention of Cerclage
Retain Cerclage until clinical removal is indicated by protocol
Procedure: Removal vs. Retention of Cervical Cerclage
Immediate removal of cerclage following randomization vs. retention of cerclage until labor, chorioamnionitis, or fetal distress
Other Name: McDonald or Shirodkar Cerclage
Active Comparator: 2 - Removal of Cerclage
Group 2 = Subjects who will have cerclage removed after randomization
Procedure: Removal of Cerclage
Immediate removal of Cerclage following randomization
Procedure: Removal vs. Retention of Cervical Cerclage
Immediate removal of cerclage following randomization vs. retention of cerclage until labor, chorioamnionitis, or fetal distress
Other Name: McDonald or Shirodkar Cerclage

Detailed Description:

The placement of cervical cerclage is standard of care for women who experience incompetent cervix. Treadwell et al, published the largest retrospective review of 482 patients receiving cerclage (364 elective and 118 emergent). They found premature rupture of membranes (PROM) in 38% of the subjects with 9% delivering <27 weeks. Preterm birth is the cause of at least 75% of neonatal deaths that are not due to congenital malformations. The question of whether to remove cerclage after preterm premature rupture of membranes (PPROM) is one of the unresolved controversies in obstetrics because the few available studies are retrospective, all have small numbers of patients, and the studies have given conflicting results regarding the safety of retaining a cerclage after preterm premature rupture of the membranes. It is unclear from the retrospective studies whether latency (the interval from membrane rupture to the onset of labor) is prolonged with retention of the suture. Furthermore, some, but not all studies suggest an increase in major infectious maternal morbidity and possibly neonatal morbidity. For this reason, clinicians vary greatly in deciding on whether to remove a cerclage in a patient with PPROM and either practice is currently an acceptable standard. This is a fairly rare complication, the combination of PPROM in a patient with cerclage in place only occurs in about 1-3/1000 pregnant women. Thus it has been impossible to study this problem prospectively in any single institution. The establishment of the Obstetrix Collaborative Research Group affords the unique opportunity to study this rare complication. Obstetrix manages 19 practices of Perinatologists around the U.S. and Mexico and is comprised of nearly 100 such subspecialists. This problem is most often referred to a Perinatologist when it occurs, so it is not unusual for these practices to see 5 - 10 such patients per year. Obstetrix fully funds the infrastructure of this research group and inclusion in this study will not alter the cost of patient care in either group as there is virtually no cost in removing the cerclage and all these patients are kept in hospital until delivery when membranes rupture as standard of care.

This is a multicenter trial. The purpose is to determine whether retention of cerclage after preterm premature rupture of the membranes improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. A previously placed prophylactic cerclage defined as any cerclage done < 23 6/7 weeks including those done for previous history of cervical incompetence, asymptomatic cervical shortening (regardless of effacement) and asymptomatic cervical dilation < 3 cm
  2. Spontaneous rupture of membranes 22-32 weeks
  3. Singleton or twin gestation
  4. Shirodkar or McDonald cerclage in place > 1 week

Exclusion Criteria:

  1. Active labor (> 8 uterine contractions [UCs] per hour)
  2. Chorioamnionitis as defined by temperature > 38 plus fetal tachycardia or uterine tenderness
  3. Placenta previa or undiagnosed vaginal bleeding
  4. Nonreassuring fetal status by nonstress test (NST) or biophysical profile (BPP)
  5. Mature pulmonary studies
  6. Positive gram stain, culture, white blood cells (WBC) > 30, or glucose < 14 on amniocentesis
  7. Major fetal anomaly
  8. Presentation > 48 hours after rupture of membranes
  9. abdominal cerclage
  10. Cerclage done for symptomatic cervical dilation (cervix dilated > 3 cm)
  11. Post amniocentesis membrane rupture (rupture which occurs within one week of amniocentesis)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00201656

Contacts
Contact: Kimberly Maurel, MSN 714-593-9171 kimberly_maurel@pediatrix.com
Contact: Diana Abril, MS CRM 480-659-8644 diana_abril@pediatrix.com

  Hide Study Locations
Locations
United States, Alabama
University of South Alabama Medical Center Withdrawn
Mobile, Alabama, United States, 36617
United States, Arizona
Desert Good Samaritan Hospital Recruiting
Mesa, Arizona, United States, 85202
Contact: Shirley Sawai, MD     602-239-2647     shirley_sawai@pediatrix.com    
Contact: Ana Braescu, RN, MSN     602-239-3632 office     Ana_braescu@pediatrix.com    
Principal Investigator: Shirley Sawai, MD            
Banner Good Samaritan Hospital Recruiting
Phoenix, Arizona, United States, 85006
Contact: Shirley Sawai, MD     602-239-2647     shirley_Sawai@pediatrix.com    
Contact: Ana Braescu, RN, MSN     602-239-3632     ana_braescu@pediatrix.com    
Principal Investigator: Shirley Sawai, MD            
Tucson Medical Center Recruiting
Tucson, Arizona, United States, 85712
Contact: Miller Hugh, MD     520-795-8188     hmiller@ahsc.arizona.edu    
Contact: Diane Mercer, RN     520-881-9662        
Principal Investigator: Hugh Miller, MD            
United States, California
Saddleback Memorial Medical Center Terminated
Laguna Hills, California, United States, 92653
Long Beach Memorial Medical Center Recruiting
Long Beach, California, United States, 90801-1428
Contact: Michael Nageotte, MD     562-933-2730     Michael_nageotte@pediatrix.com    
Contact: Christine Preslicka, RN     562-933-2730     CPreslicka@memorialcare.org    
Principal Investigator: Michael Nageotte, MD            
University of Southern California-Irvine Medical Center Terminated
Orange, California, United States, 92868
Good Samaritan Hospital Recruiting
San Jose, California, United States, 95124
Contact: Andrew Combs, MD     408-371-7111     andrew_combs@pediatrix.com    
Contact: Kimberly Mallory, RN     408-559-2327     kimberly_mallory@pediatrix.com    
Principal Investigator: Andrew Combs, MD            
Santa Clara Valley Medical Center Withdrawn
San Jose, California, United States, 95128
United States, Colorado
Presbyterian/St Luke's Hospital Terminated
Denver, Colorado, United States, 80218
Rose Medical Center Terminated
Denver, Colorado, United States, 80220
Swedish Medical Center Terminated
Denver, Colorado, United States, 80110
University of Colorado Hospital Withdrawn
Denver, Colorado, United States, 80262
United States, Connecticut
Yale New-Haven Medical Center Terminated
New Haven, Connecticut, United States, 06504
United States, Georgia
Memorial Health University Medical Center Withdrawn
Savannah, Georgia, United States, 31404
United States, Illinois
University of Illinois at Chicago Terminated
Chicago, Illinois, United States, 60612
United States, Louisiana
Lousiana State University Health Science Terminated
Shreveport, Louisiana, United States, 60612
United States, Michigan
Hutzel Women's Hospital Recruiting
Detroit, Michigan, United States, 48201
Contact: Shobha Mehta, MD     313-745-0499     smehta@med.wayne.edu    
Principal Investigator: Shobha Mehta, MD            
United States, Missouri
Saint Luke's Hospital, Kansas City Recruiting
Kansas City, Missouri, United States, 64111
Contact: George Lu     816-932-6903     glu@saint-lukes.org    
Principal Investigator: George Lu, MD            
Mercy Hospital of St. Louis Not yet recruiting
St. Louis, Missouri, United States, 63141
Contact: Bruce Morris, MD     314-991-5000     bmorrismfm@gmail.com    
Contact: Nancy Bubenik, NP     314-991-5000     nancy_bubenik@pediatrix.com    
Principal Investigator: Bruce Morris, MD            
United States, Nevada
Sunrise Medical Center Recruiting
Las Vegas, Nevada, United States, 89109
Contact: Brian Iriye, MD     702-382-3200 ext 1     biriye@mfmcenter.com    
Principal Investigator: Brian Iriye, MD            
Summerlin Hospital Withdrawn
Las Vegas, Nevada, United States, 89106
United States, New York
University of Rochester Medical Center Recruiting
Rochester, New York, United States, 14642
Contact: Tulin Ozcan, MD     585-275-7824     tulinozcan27@hotmail.com    
Principal Investigator: Tulin Ozcan, MD            
United States, Ohio
The University Hospital Terminated
Cincinnati, Ohio, United States, 45219
United States, Oregon
Sacred Heart Medical Center Terminated
Eugene, Oregon, United States, 97401
United States, Tennessee
Erlanger Medical Center Recruiting
Chattanooga, Tennessee, United States, 37403
Contact: David Adair, MD     423-664-4460        
Contact: Lorrie Mason, RN     423-664-4460     lorrie@rocob.com    
Principal Investigator: David Adair, MD            
United States, Texas
Memorial Hermann Children's Hospital-Texas Center for Fetal Assessment Recruiting
Houston, Texas, United States, 77030
Contact: Ramirez Mildred, MD     713-500-6423        
Principal Investigator: Mildred Ramirez, MD            
United States, Utah
University of Utah Health Sciences Center Withdrawn
Salt Lake City, Utah, United States, 84132
United States, Washington
Evergreen Hospital Terminated
Kirkland, Washington, United States, 98034
Swedish Medical Center Recruiting
Seattle, Washington, United States, 98122-4307
Contact: David Luthy, MD     206-386-2101     david_luthy@pediatrix.com    
Contact: Tina Lopez, RN     206-215-3541     tina_lopez@pediatrix.com    
Principal Investigator: David Luthy, MD            
Sub-Investigator: David Gorenberg, MD            
Sponsors and Collaborators
Obstetrix Medical Group
Investigators
Study Director: Kimberly Maurel, RN, MSN, CNS Obstetrix Medical Group, Inc.
  More Information

Additional Information:
Publications:
Responsible Party: Obstetrix Medical Group
ClinicalTrials.gov Identifier: NCT00201656     History of Changes
Other Study ID Numbers: OBX0002, OBX0002
Study First Received: September 13, 2005
Last Updated: January 2, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Obstetrix Medical Group:
PPROM
Cerclage
Preterm Premature Rupture of the Membranes with Cerclage

Additional relevant MeSH terms:
Fetal Membranes, Premature Rupture
Rupture
Obstetric Labor Complications
Pregnancy Complications
Wounds and Injuries

ClinicalTrials.gov processed this record on May 23, 2013